Protalix BioTherapeutics, Inc (PLX) Stock Price

2.25 ▲ +0.06 (+2.74%)
Open: 2.25 Vol: 867.39K Day's range: 2.21 - 2.29 Apr 08, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PLX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.25▼ 2.23▲ 2.24▲ 2.20▲ 2.30▼
MA10 2.24▲ 2.25▲ 2.23▲ 2.17▲ 2.59▼
MA20 2.23▲ 2.23▲ 2.21▲ 2.33▼ 2.25▼
MA50 2.25▲ 2.19▲ 2.17▲ 2.61▼ 1.97▲
MA100 2.23▲ 2.16▲ 2.16▲ 2.23▲ 1.81▲
MA200 2.20▲ 2.18▲ 2.49▼ 2.03▲ 1.68▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ -0.004▼ 0.003▲ 0.008▲ -0.047▼
RSI 58.693▲ 58.089▲ 59.076▲ 43.561▼ 50.139▲
STOCH 92.857▲ 32.318     65.137     69.630     30.805    
WILL %R -11.111▲ -33.333     -21.429▲ -15.385▲ -63.946    
CCI 91.609     -13.333     54.040     173.904▲ -44.439    
Latest Filters Detected On PLX
▲ MACD $PLX MACD(12,26,9) Crossed Above Signal Line Set Alert
▲ GAP $PLX Open Gap Up %2 Set Alert
CDL $PLX Doji Candlestick Pattern Detected Set Alert
Protalix BioTherapeutics, Inc News
Protalix Revenue Miss Overshadowed By Milestone-Backed 2026 Guidance
Tuesday, March 24, 2026 11:42 AM
Protalix BioTherapeutics, Inc. is rated a Buy due to robust FY26 revenue guidance of $78–83 million. Learn more about PLX stock here.
Protalix BioTherapeutics advances Fabry disease and gout programs during 2025
Wednesday, March 18, 2026 07:13 AM
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined recent regulatory, clinical and commercial developments, including a new European approval for its ...
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Tuesday, March 17, 2026 01:30 AM
Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX‑200 across multiple lysosomal storage disorders PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Polaryx ...
PLX historical stock data
date open high low close volume
08/04/26 2.25 2.29 2.21 2.25 867,390
07/04/26 2.19 2.215 2.14 2.19 407,425
06/04/26 2.15 2.23 2.13 2.21 651,365
02/04/26 2.15 2.16 2.0731 2.15 1,039,890
01/04/26 2.21 2.26 2.17 2.19 863,776
31/03/26 2.10 2.20 2.095 2.17 966,911
30/03/26 2.11 2.12 2.045 2.09 1,020,588
27/03/26 2.10 2.21 2.09 2.14 716,737
26/03/26 2.14 2.175 2.06 2.11 888,922
25/03/26 2.08 2.18 2.07 2.16 1,105,800
Quote Details
52wk Low:1.32
52wk High:3.19
Vol:867.39K
Avg Vol(3m):20.8M
1Y Chng:-23.47%
1M Chng:-25.74%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 178.06M